Omeros Corporation
OMER
#6695
Rank
โ‚น68.22 B
Marketcap
โ‚น942.63
Share price
0.61%
Change (1 day)
191.46%
Change (1 year)

Earnings for Omeros Corporation (OMER)

Earnings in 2025 (TTM): -โ‚น10.33 Billion

According to Omeros Corporation's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚น15.12 Billion a decrease over its 2023 earnings that were of -โ‚น13.79 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Omeros Corporation from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น10.33 Billion-31.71%
2024 -โ‚น15.12 Billion9.63%
2023 -โ‚น13.79 Billion-9.57%
2022 -โ‚น15.25 Billion-30.65%
2021 -โ‚น21.99 Billion86.28%
2020 -โ‚น11.81 Billion99.45%
2019 -โ‚น5.92 Billion-49.91%
2018 -โ‚น11.82 Billion190.77%
2017 -โ‚น4.07 Billion-27.96%
2016 -โ‚น5.64 Billion-17.61%
2015 -โ‚น6.85 Billion1.88%
2014 -โ‚น6.72 Billion87.56%
2013 -โ‚น3.59 Billion
2011 -โ‚น2.63 Billion-8.96%
2010 -โ‚น2.89 Billion45.03%
2009 -โ‚น1.99 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.486 T-21,832.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น1.013 T-8,959.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
-โ‚น0.37 Billion-96.77%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Eterna Therapeutics
ERNA
-โ‚น0.91 Billion-92.06%๐Ÿ‡บ๐Ÿ‡ธ USA